The use of alpha-blockers for the treatment of nephrolithiasis
- PMID: 17216000
- PMCID: PMC1765041
The use of alpha-blockers for the treatment of nephrolithiasis
Abstract
Medical expulsion therapy has been shown to be a useful adjunct to observation in the management of ureteral stones. Alpha-1-adrenergic receptor antagonists have been studied in this role. Alpha-1 receptors are located in the human ureter, especially the distal ureter. Alpha-blockers have been demonstrated to increase expulsion rates of distal ureteral stones, decrease time to expulsion, and decrease need for analgesia during stone passage. Alpha-blockers promote stone passage in patients receiving shock wave lithotripsy, and may be able to relieve ureteral stent-related symptoms. In the appropriate clinical scenario, the use of alpha-blockers is recommended in the conservative management of distal ureteral stones.
Figures
References
-
- Segura JW, Preminger GM, Assimos DG, et al. Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi. J Urol. 1997;158:1915–1921. - PubMed
-
- Hollingsworth JM, Rogers MAM, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006;368:1171–1179. - PubMed
-
- Malin JM, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol. 1970;42:171–174. - PubMed
-
- Sigala S, Dellabella M, Milanese G, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodynamics. 2005;24:142–148. - PubMed
-
- Weiss RM, Bassett AL, Hoffman BF. Adrenergic innervation of the ureter. Invest Urol. 1978;16:123–127. - PubMed
LinkOut - more resources
Full Text Sources
Medical